PVMCV

Polaris Venture Management Co V Portfolio holdings

AUM $14.1M
This Quarter Return
-8.45%
1 Year Return
+121.41%
3 Year Return
+278.88%
5 Year Return
+1,121.38%
10 Year Return
AUM
$127M
AUM Growth
+$127M
Cap. Flow
+$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
9
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 79.02%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
TRVN
1
DELISTED
Trevena, Inc.
TRVN
$28M 22.02%
2,669,280
TTOO
2
DELISTED
T2 Biosystems, Inc
TTOO
$22.1M 17.35%
2,018,450
ATYR
3
aTyr Pharma
ATYR
$527M
$18M 14.12%
1,827,992
PULM icon
4
Pulmatrix
PULM
$18M
$15.2M 11.9%
3,607,996
OCUL icon
5
Ocular Therapeutix
OCUL
$2.12B
$11.5M 9.05%
1,230,009
GNCA
6
DELISTED
Genocea Biosciences, Inc.
GNCA
$10.4M 8.15%
1,968,606
DARE icon
7
Dare Bioscience
DARE
$27.2M
$9.21M 7.23%
3,287,529
FATE icon
8
Fate Therapeutics
FATE
$120M
$8.34M 6.55%
2,473,186
BIND
9
DELISTED
BIND THERAPEUTICS INC
BIND
$4.62M 3.63%
2,018,253